Nanotechnology News

RSS

Wear Plays a Critical Role in Design of Nanomachines

As nanomachine design rapidly advances, researchers are moving from wondering if the nanomachine works to how long it will work. This is an especially important question as there are so many potential applications, for instance, for medical uses, including drug delivery, early diagnosis, disease monitoring, instrumentation, and surgery.

27 Jan 2015

Researchers Discover Unknown Way for RAS Protein to Find Proper Place in Cells

Three of the four most fatal cancers are caused by a protein known as Ras; either because it mutates or simply because it ends up in the wrong place at the wrong time. Ras has proven an elusive target for scientist trying to cure the deadly diseases. Now a group from the Department of Chemistry, University of Copenhagen have discovered an unknown way for RAS to find its proper place in the cell. Their discovery may lead to completely novel approaches to curing cancer.

27 Jan 2015

Attaching Epirubicin to Nanodiamonds Effectively Eliminates Chemoresistant Cancer Stem Cells

A study led by the National University of Singapore (NUS) found that attaching chemotherapy drug Epirubicin to nanodiamonds effectively eliminates chemoresistant cancer stem cells. The findings were first published online in ACS Nano, the official journal of the American Chemical Society, in December 2014.

27 Jan 2015

Ornek Makine Ships Yarn Heat Setting Machine with Industrial Nanotech’s High Heat and EPX Thermal Insulation Coatings

Industrial Nanotech, Inc., an emerging global leader in nanotechnology based energy saving solutions, today announced that the Company’s patented thermal insulation and protective coatings are now being used as an OEM (original equipment manufacturer) upgrade application on new textile machinery.

From Industrial Nanotech, Inc. 27 Jan 2015

Graphene Nanoribbons Can Be Fracture to Get Desired Edges

Theoretical physicists at Rice University are living on the edge as they study the astounding properties of graphene. In a new study, they figure out how researchers can fracture graphene nanoribbons to get the edges they need for applications.

27 Jan 2015

Researchers Investigate Cyclic Loading of Silver Nanowires for Electronics Applications

With its high electrical conductivity and optical transparency, indium tin oxide is one of the most widely used materials for touchscreens, plasma displays, and flexible electronics. But its rapidly escalating price has forced the electronics industry to search for other alternatives.

27 Jan 2015

BIND Therapeutics Acquires Additional Funding to Accelerate Growth of Accurin

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that it has entered into an amendment of its existing credit facility from Hercules Technology III, L.P., an affiliate of Hercules Technology Growth Capital. Under the amendment, the company borrowed an additional $15 million in growth capital, less the repayment of the outstanding balance on BIND’s existing term loan facility of approximately $3 million.

27 Jan 2015

SUNY EVP to Present on Nanoelectronics

Michael Liehr, Executive Vice President of Innovation and Technology at the State University of New York (SUNY) Polytechnic Institute, will give a talk at 10 a.m. Friday, Jan. 30, in Room 1065 of Kemper Hall on the UC Davis campus. The event is hosted by S.J. Ben Yoo, a professor in the UC Davis Department of Electrical and Computer Engineering. The talk is presented as part of the College of Engineering’s Distinguished Lecture Series.

27 Jan 2015

EMA CHMP Adopts Positive Opinion for ABRAXANE-Carboplatin Combination for Treatment of NSCLC

Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation, today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for ABRAXANE® (paclitaxel formulated as albumin-bound nanoparticles, or nab-paclitaxel) in combination with carboplatin for the first-line treatment of non-small cell lung cancer in adult patients who are not candidates for potentially curative surgery and/or radiation therapy.

27 Jan 2015

NanoViricides Reports Good Safety Profile of Optimized FluCide Drug Candidate in GLP-Like Toxicology Study

NanoViricides, Inc. (the "Company"), a nanomedicine company developing anti-viral drugs, reported a good safety profile of an optimized FluCide® drug candidate in a GLP-like toxicology study in rats. These results are extremely important since they indicate that FluCide continues to look very promising as one of the most advanced candidates in the Company's drug development pipeline.

From NanoViricides, Inc 27 Jan 2015

$STOE Announce New Module for WinXPOW Powder Diffraction Software$

STOE Announce New Module for WinXPOW Powder Diffraction Software

STOE's WinXPOW software now includes a new module for easy evaluation of powder diffraction measurements - SYSTEVAL.

From STOE 26 Jan 2015

Nanotechnologists Use Gold ‘Nanodrills’ for DNA Analysis

Scientists from the University of Twente have developed spherical gold particles which are capable of drilling a nano-diameter tunnel in a ceramic material upon heating.

26 Jan 2015

NanoViricides Ships anti-Ebola Broad-Spectrum Drug Candidates for BSL-4 Level Testing

NanoViricides, Inc., a nanomedicine company developing anti-viral drugs, reported that it has shipped several anti-Ebola nanoviricide® drug candidates to a hi-security bio-containment facility in the US that is capable of performing evaluation of these drug candidates in the required biological safety level 4 (BSL-4) environment.

From NanoViricides, Inc 23 Jan 2015

Global Carbon Nanotubes Market Expected to Grow at 14.84% CAGR

TechNavio, a tech-focused research firm, has published a new report on the Global Carbon Nanotubes (CNTs) Market, which is expected to grow at a CAGR of 14.84 percent from 2014-2019.

23 Jan 2015

BIND Therapeutics Co-Founder Provides Vision of Therapeutic Improvements in “Science and Medicine: Nanotechnology”

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, today announced the publication of an article in the Journal of the American Medical Association (JAMA) co-authored by Robert S. Langer, Sc.D, David H. Koch Institute Professor, Massachusetts Institute of Technology, co-founder and member of the Board of Directors of BIND and one of seven individuals to have received both the United States National Medal of Science and the United States National Medal of Technology and Innovation.

23 Jan 2015

Nanotechnology News

Wear Plays a Critical Role in Design of Nanomachines

Researchers Discover Unknown Way for RAS Protein to Find Proper Place in Cells

Attaching Epirubicin to Nanodiamonds Effectively Eliminates Chemoresistant Cancer Stem Cells

Ornek Makine Ships Yarn Heat Setting Machine with Industrial Nanotech’s High Heat and EPX Thermal Insulation Coatings

Graphene Nanoribbons Can Be Fracture to Get Desired Edges

Researchers Investigate Cyclic Loading of Silver Nanowires for Electronics Applications

BIND Therapeutics Acquires Additional Funding to Accelerate Growth of Accurin

SUNY EVP to Present on Nanoelectronics

EMA CHMP Adopts Positive Opinion for ABRAXANE-Carboplatin Combination for Treatment of NSCLC

NanoViricides Reports Good Safety Profile of Optimized FluCide Drug Candidate in GLP-Like Toxicology Study

STOE Announce New Module for WinXPOW Powder Diffraction Software

Nanotechnologists Use Gold ‘Nanodrills’ for DNA Analysis

NanoViricides Ships anti-Ebola Broad-Spectrum Drug Candidates for BSL-4 Level Testing

Global Carbon Nanotubes Market Expected to Grow at 14.84% CAGR

BIND Therapeutics Co-Founder Provides Vision of Therapeutic Improvements in “Science and Medicine: Nanotechnology”

News Categories

First Look into the Electrostatic Landscape of a Moiré Unit Cell

Nanostructured Plasma Engineering Extends the Life of Industrial Steel

Could Graphene Memristors Tackle AI's Energy Use?

Optofluidic 3D Micro/Nanofabrication for Diverse Materials and Multifunctional Microdevices

Nanotoxicology Moves Beyond Short Term to Integrated Safety Frameworks

Enhancing Lipid Nanoparticle Stability for Faster Pharmaceutical Development

Turning Almond Shells into Electronics: A Conversation on Laser-Induced Graphene

Enhancing Slurry Stability in Lithium-Ion Batteries with Turbiscan Technology

Featured Articles

Nanomedicine in 2026: Experts Predict the Year Ahead

Policy, Safety, and Regulation in the Age of Nanotechnology

Additive Nanomanufacturing: What is it and How Does it Work?

Sponsored Content

Understanding Single-Particle Optical Sensing for Particle Characterization

Nanoarchitected Metamaterials Fabricated via Two-Photon Lithography (TPL)

Measuring MEMS Micromirror Dynamics with 4D Digital Holographic Microscopy

Automating Zeta Potential Measurements for Liposomes in High and Low Salt Environments